Literature DB >> 6590431

Loperamide has antisecretory activity in the human jejunum in vivo.

S Hughes, N B Higgs, L A Turnberg.   

Abstract

We investigated the possibility that loperamide might influence absorption and secretion in the human jejunum in vivo. Using a triple lumen tube perfusion technique in healthy normal volunteers we showed that loperamide did not affect net absorption of water or electrolytes under basal condition. When secretion was induced by prostaglandin E2, however, loperamide significantly reduced that secretion and in three out of six subjects secretion was abolished. Loperamide was effective when it was given either before or after secretion had been initiated. The results lend support to the suggestion that the antidiarrhoeal activities of loperamide may include an antisecretory effect.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6590431      PMCID: PMC1432486          DOI: 10.1136/gut.25.9.931

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Effects of morphine and other drugs on motility of the terminal ileum.

Authors:  E E DANIEL; W H SUTHERLAND; A BOGOCH
Journal:  Gastroenterology       Date:  1959-04       Impact factor: 22.682

2.  Control of guinea pig intestinal electrolyte secretion by a delta-opiate receptor.

Authors:  J F Kachur; R J Miller; M Field
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

3.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues.

Authors:  J M Van Nueten; P A Janssen; J Fontaine
Journal:  Arzneimittelforschung       Date:  1974-10

4.  Active chloride secretion in the normal human jejunum.

Authors:  G R Davis; C A Santa Ana; S Morawski; J S Fordtran
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

5.  The mechanisms of sodium absorption in the human small intestine.

Authors:  J S Fordtran; F C Rector; N W Carter
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

6.  Studies of the antisecretory activity of morphine in rabbit ileum in vitro.

Authors:  J S McKay; B D Linaker; N B Higgs; L A Turnberg
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

7.  Loperamide in severe protracted diarrhoea.

Authors:  B K Sandhu; J H Tripp; P J Milla; J T Harries
Journal:  Arch Dis Child       Date:  1983-01       Impact factor: 3.791

8.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 7: Clinical investigation. Efficacy and safety of loperamide in patients with severe chronic diarrhea.

Authors:  H Verhaegen; J De Cree; V Schuermans
Journal:  Arzneimittelforschung       Date:  1974-10

9.  Loperamide: studies on its mechanism of action.

Authors:  B K Sandhu; J H Tripp; D C Candy; J T Harries
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

10.  Studies of the mechanism of the antidiarrheal effect of codeine.

Authors:  L R Schiller; G R Davis; C A Santa Ana; S G Morawski; J S Fordtran
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

View more
  25 in total

1.  The effect of Aloe ferox Mill. in the treatment of loperamide-induced constipation in Wistar rats.

Authors:  Olubunmi A Wintola; Taofik O Sunmonu; Anthony J Afolayan
Journal:  BMC Gastroenterol       Date:  2010-08-19       Impact factor: 3.067

2.  Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity.

Authors:  G Stacher; H Steinringer; C Schneider; G V Vacariu-Granser; F Castiglione; G Gaupmann; U Weber; G Stacher-Janotta
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

3.  Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide.

Authors:  E B Chang; D R Brown; N S Wang; M Field
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea.

Authors:  J D O'Brien; D G Thompson; A McIntyre; W R Burnham; E Walker
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

5.  Subcutaneous loperamide prevents gastric lesions induced by necrotizing agents in rats.

Authors:  Y Hatakeyama; M Tomoi; M Ohtsuka; K Shimomura
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

6.  Laxative activities of Mareya micrantha (Benth.) Müll. Arg. (Euphorbiaceae) leaf aqueous extract in rats.

Authors:  Souleymane Méité; Calixte Bahi; Dodéhé Yéo; Jacques Y Datté; Joseph A Djaman; David J N'guessan
Journal:  BMC Complement Altern Med       Date:  2010-02-16       Impact factor: 3.659

Review 7.  Racecadotril versus loperamide: antidiarrheal research revisited.

Authors:  S Huighebaert; F Awouters; G N J Tytgat
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Effect of increasing oral doses of loperamide on gallbladder motility in man.

Authors:  W P Hopman; G Rosenbusch; J B Jansen; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

9.  Effect of lidamidine, a proposed alpha 2-adrenoreceptor agonist, on salt and water transport in human jejunum.

Authors:  C A Edwards; N W Read
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

10.  Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro.

Authors:  W Kromer
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.